Načítá se...
The rationale and timing of molecular genetic testing for dilated cardiomyopathy
The genetic evaluation of dilated cardiomyopathy (DCM) has been challenging, owing in large part to marked genetic heterogeneity. However, lower costs from next generation sequencing have enabled gene discovery and the expansion of genetic testing panels. These advances have improved molecular diagn...
Uloženo v:
| Vydáno v: | Can J Cardiol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5875986/ https://ncbi.nlm.nih.gov/pubmed/26518443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cjca.2015.06.034 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|